SCHEMBL4875754

SCHEMBL4875754

CC(C)C(=O)c1ccc(C(N)=O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 9/20 0.55
RECQL P46063 2/20 0.52
KDM4E B2RXH2 1/20 0.52
DBH P09172 1/20 0.52
GAA P10253 1/20 0.52
CA2 P00918 3/20 0.50
PARP4 Q9UKK3 2/20 0.50
PARP1 P09874 2/20 0.50
CA1 P00915 2/20 0.50
PARP2 Q9UGN5 1/20 0.50
PARP15 Q460N3 2/20 0.48
ALDH1A1 P00352 2/20 0.48
KMT2A Q03164 1/20 0.48
PARP14 Q460N5 1/20 0.48
PARP16 Q8N5Y8 1/20 0.48
PARP11 Q9NR21 1/20 0.48
TSHR P16473 2/20 0.48
HSD17B10 Q99714 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10121174 0.87 KDM4E (0.62) PARP10RECQLKDM4EDBHGAA
SCHEMBL2449415 0.81 KDM4E (0.52) PARP10RECQLKDM4EDBHGAA
SCHEMBL24671657 0.81 RECQL (0.47) PARP10RECQLKDM4EDBHGAA
SCHEMBL12418688 0.80 KDM4E (0.56) RECQLKDM4EDBHGAAALDH1A1
SCHEMBL10941943 0.80 KDM4E (0.56) RECQLKDM4EDBHGAAALDH1A1
Terephthalamide SCHEMBL23774 0.79 PARP1 (0.71) PARP10RECQLGAACA2PARP4
SCHEMBL9340081 0.78 GAA (0.54) RECQLKDM4EDBHGAAALDH1A1
SCHEMBL585256 0.78 ALDH1A1 (0.56) RECQLKDM4EDBHGAAALDH1A1
SCHEMBL4378592 0.78 KDM4E (0.59) RECQLKDM4EDBHGAACA2
SCHEMBL1878288 0.78 TSHR (0.60) RECQLKDM4EDBHGAACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8729114-B2 Heteroaryl nitrile compounds useful as inhibitors of Cathepsin-S BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-20 US disclosed
US-8729114-B2 Heteroaryl nitrile compounds useful as inhibitors of Cathepsin-S BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-20 US disclosed
US-20130158018-A1 Heteroaryl Nitrile Compounds Useful as Inhibitors of Cathepsin-S BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 US disclosed
US-20130158018-A1 Heteroaryl Nitrile Compounds Useful as Inhibitors of Cathepsin-S BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 US disclosed
US-7470722-B2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease KALYPSYS, INC. (US) 2008-12-30 US disclosed
US-20060030543-A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease KALYPSYS, INC. 2006-02-09 US disclosed
WO-2005123089-A2 MULTICYCLIC SULFONAMIDE COMPOUNDS AS INHIBITORS OF HISTONE DEACETYLASE FOR THE TREATMENT OF DISEASE KALYPSYS, INC. (US) 2005-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060030543-A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease HDAC6, HDAC3, HDAC5 PARP10 1240/4885RECQL 1362/4885KDM4E 546/4885
US-20130158018-A1 Heteroaryl Nitrile Compounds Useful as Inhibitors of Cathepsin-S CTSS, CTSV, CTSF PARP10 2771/4885RECQL 2182/4885KDM4E 3949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.